Identification, Mapping and Relative Quantitation of SARS-CoV-2 Spike Glycopeptides by Mass-Retention Time Fingerprinting

R. Chalk; W. Greenland; T. Moreira; J. Coker; S.M.M Mukhopadhyay; E. Williams; C. Manning; T. Bohstedt; R. McCrorie; A. Fernandez-Cid; N.A. Burgess-Brown

doi:10.1101/2020.07.24.217562

Article Information

doi

https://doi.org/10.1101/2020.07.24.217562

History

July 27, 2020.

Article Versions

Version 1 (July 24, 2020 - 16:15).
You are viewing Version 2, the most recent version of this article.

The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

R. Chalk1,*,
W. Greenland2,
T. Moreira1,
J. Coker1,
S.M.M Mukhopadhyay1,
E. Williams1,
C. Manning1,
T. Bohstedt1,
R. McCrorie1,
A. Fernandez-Cid1 and
N.A. Burgess-Brown1

¹Centre for Medicines Discovery, ORCRB, Oxford University, OX3 7DQ, UK
²Agilent Technologies, Lakeside, Cheadle Royal Business Park, Cheadle, Cheshire, SK8 3GR, UK